Acquisition deepens Furst Group’s biotechnology and biopharma, diagnostics, life science tools and services, and MedTech search expertise, building on 40-plus years of healthcare and life sciences executive search and leadership solutions.
FOR IMMEDIATE RELEASE – September 9, 2026 – Furst Group, a premier executive search and leadership solutions firm serving the healthcare and life sciences industries, today announced the acquisition of Legacy BioSearch Partners, a retained executive search firm serving biotechnology and life sciences organizations.
The acquisition builds on a series of recent additions significantly deepening Furst Group’s life sciences capabilities across biotechnology and biopharma, diagnostics and precision medicine, life science tools and services, and MedTech, further extending the firm’s reach across the healthcare and life sciences continuum.
Legacy BioSearch Partners was founded by John Cummings, who, as part of the acquisition, joins Furst Group as Senior Client Partner. Cummings, having partnered with organizations across every stage of growth, from venture- and private equity-backed startups to established global enterprises, brings extensive experience in executive search and talent advisory. His work spans C-Suite and senior functional leadership searches across R&D, clinical development, medical affairs, operations, finance, commercial, and other critical functions.
“This acquisition reflects our commitment to meeting the evolving needs of healthcare and life sciences organizations,” said Bob Clarke, Chairman of Furst Group and NuBrick Partners. “John’s expertise and relationships, combined with our decades of experience across the healthcare and life sciences ecosystem, position us to serve as a true leadership partner to organizations navigating growth, transformation, and every critical inflection point in between.”
“We’ve worked with life sciences organizations for a number of years, and John’s experience sharpens that focus,” said Sherrie Barch, CEO of Furst Group and NuBrick Partners. “Together, we’re positioned to bring our full range of services including executive search, leadership development, team performance, and succession planning, to organizations as they grow and evolve.”
“I’ve long respected Furst Group’s depth of knowledge and the rigor they bring to every search,” said Cummings. “Pairing my life sciences relationships, executive search experience, and personalized approach with Furst Group and NuBrick Partners’ scale, resources, and leadership expertise means delivering high-touch partnerships that help organizations build the teams they need to execute their vision and navigate what comes next.”
The Legacy BioSearch Partners acquisition underscores Furst Group’s continued investment in expanding its capabilities across the healthcare and life sciences ecosystem. Furst Group has been ranked among the Top 10 Healthcare Executive Search Firms by Modern Healthcare and one of America’s Best Executive Recruiting Firms by Forbes.
About Furst Group & NuBrick Partners
The Companies of MPI, Furst Group and NuBrick Partners, provide executive search and leadership solutions across the healthcare and life sciences ecosystem. Together, the firms partner with clients to identify and evaluate the talent, leadership, and culture needed to execute strategy and achieve sustained success, offering executive search alongside leadership development, team performance, succession planning, and organizational assessment. NuBrick Partners also extends their capabilities and expertise to organizations across industries beyond healthcare and life sciences. Learn more by visiting https://mpi-companies.com.
